Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
企業コードCSBR
会社名Champions Oncology Inc
上場日Nov 30, 1988
最高経営責任者「CEO」Dr. Ronnie Morris, M.D.
従業員数213
証券種類Ordinary Share
決算期末Nov 30
本社所在地One University Plaza,
都市HACKENSACK
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号07601
電話番号12018088400
ウェブサイトhttps://championsoncology.com
企業コードCSBR
上場日Nov 30, 1988
最高経営責任者「CEO」Dr. Ronnie Morris, M.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし